Niche Oncology Focus The firm’s exclusive focus on oncology markets enables premium, recurring advisory services for pharma and biotech clients seeking ongoing competitive intelligence and strategic market planning for solid tumor, hematologic, IO, and MOA programs.

Growth Areas Rising demand in immuno-oncology and MOA assets makes expansion into ongoing forecasting, pipeline mapping, and scenario planning a natural upsell from static reports to multi-quarter engagements.

Agile Niche Firm Lean, US-based team and Palo Alto location enable nimble, senior-led engagements with mid-sized biopharma and specialty firms, offering high-value insights with faster timelines and lower overhead than large firms.

Data-Driven Credibility Data capabilities supported by the tech stack allow scalable research outputs, dashboards, and continuous market monitoring that can be productized into subscription services or multi-project engagements.

Founder Leadership Founder-led oncology expertise provides credibility for enterprise partnerships with large pharma, enabling collaborative go-to-market, thought leadership opportunities, and strategic alliances.